- Home
- GEG vs RPTX Comparison
GEG vs RPTX Comparison
Compare GEG & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GEG
- RPTX
- Stock Information
- Founded
- GEG 1994
- RPTX 2016
- Country
- GEG United States
- RPTX Canada
- Employees
- GEG N/A
- RPTX N/A
- Industry
- GEG Computer Software: Prepackaged Software
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- GEG Technology
- RPTX Health Care
- Exchange
- GEG Nasdaq
- RPTX Nasdaq
- Market Cap
- GEG 57.0M
- RPTX 63.9M
- IPO Year
- GEG N/A
- RPTX 2020
- Fundamental
- Price
- GEG $2.17
- RPTX $1.56
- Analyst Decision
- GEG
- RPTX Strong Buy
- Analyst Count
- GEG 0
- RPTX 3
- Target Price
- GEG N/A
- RPTX $4.50
- AVG Volume (30 Days)
- GEG 6.0K
- RPTX 717.8K
- Earning Date
- GEG 08-28-2025
- RPTX 08-05-2025
- Dividend Yield
- GEG N/A
- RPTX N/A
- EPS Growth
- GEG N/A
- RPTX N/A
- EPS
- GEG N/A
- RPTX N/A
- Revenue
- GEG $19,626,000.00
- RPTX $1,073,000.00
- Revenue This Year
- GEG N/A
- RPTX N/A
- Revenue Next Year
- GEG N/A
- RPTX N/A
- P/E Ratio
- GEG N/A
- RPTX N/A
- Revenue Growth
- GEG 64.34
- RPTX N/A
- 52 Week Low
- GEG $1.70
- RPTX $0.89
- 52 Week High
- GEG $2.33
- RPTX $4.22
- Technical
- Relative Strength Index (RSI)
- GEG 56.38
- RPTX 58.19
- Support Level
- GEG $2.09
- RPTX $1.37
- Resistance Level
- GEG $2.21
- RPTX $1.68
- Average True Range (ATR)
- GEG 0.09
- RPTX 0.08
- MACD
- GEG 0.01
- RPTX 0.00
- Stochastic Oscillator
- GEG 82.61
- RPTX 61.29
About GEG Great Elm Group Inc.
Great Elm Group Inc operates as an alternative asset manager focused on growing a scalable and diversified portfolio of long-duration and permanent capital vehicles across credit, real estate, specialty finance, and other alternative strategies. Along with its subsidiaries, it manages Great Elm Capital Corp, a publicly traded business development company, and Monomoy Properties REIT, LLC, an industrial-focused real estate investment trust, in addition to other investments.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.